Development and validation of a renal risk score in ANCA-associated glomerulonephritis-Reference-Cited by-同舟云学术

Development and validation of a renal risk score in ANCA-associated glomerulonephritis

Published:2018-12 Issue:6 Volume:94 Page:1177-1188
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Brix Silke R.,Noriega Mercedes,Tennstedt Pierre,Vettorazzi Eik,Busch Martin,Nitschke Martin,Jabs Wolfram J.,Özcan Fedai,Wendt Ralph,Hausberg Martin,Sellin Lorenz,Panzer Ulf,Huber Tobias B.,Waldherr Rüdiger,Hopfer Helmut,Stahl Rolf A.K.,Wiech Thorsten

Funder

Deutsche Forschungsgemeinschaft

Publisher

Elsevier BV

Subject

Nephrology

Reference47 articles.

1. Rituximab versus cyclophosphamide for ANCA-associated vasculitis;Stone;N Engl J Med,2010

2. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis;Jones;N Engl J Med,2010

3. Induction regimens for ANCA-associated vasculitis;Specks;N Engl J Med,2013

4. Antineutrophil cytoplasm antibody-associated vasculitis: recent developments;Furuta;Kidney Int,2013

5. Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis;Bajema;Kidney Int,1999

Cited by 200 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Granulomatosis with polyangiitis: clinical characteristics and updates in diagnosis;Frontiers in Medicine;2024-08-27

2. Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in China: Epidemiology, Management, Prognosis, and Outlook;Kidney Diseases;2024-08-05

3. Performance of clinical and histological prognostic scores for kidney survival in ANCA-associated vasculitis;Rheumatology;2024-06-14

4. Evaluating Single-Nucleotide Polymorphisms in Inflammasome Proteins and Serum Levels of IL-18 and IL-1β in Kidney Interstitial Damage in Anti-Neutrophilic Cytoplasmic Antibody-Associated Vasculitis;International Journal of Molecular Sciences;2024-06-12

5. Prognosis of microscopic polyangiitis is well predictable in the first 2 weeks of treatment;Clinical and Experimental Nephrology;2024-06-08